| Drug Type Small molecule drug | 
| Synonyms INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER | 
| Target- | 
| Action- | 
| Mechanism Calcium supplements, Sodium supplements | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseWithdrawn | 
| First Approval Date United States (26 Mar 1986),  | 
| Regulation- | 
| Molecular FormulaClNa | 
| InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M | 
| CAS Registry7647-14-5 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Water-Electrolyte Imbalance | United States  | 26 Mar 1986 | 





